A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata.

Indian Dermatol Online J · 2026 · PMC13395296 · PMID 42340817

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

SALT90 was achieved at 6 months by 33.3% (6/18) of patients in Group A and 11.1% (2/18) in Group B ( P = 0.10), representing a numerical trend.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.